211 related articles for article (PubMed ID: 21530092)
1. Evaluation of cognitive behavioral therapy/motivational enhancement therapy (CBT/MET) in a treatment trial of comorbid MDD/AUD adolescents.
Cornelius JR; Douaihy A; Bukstein OG; Daley DC; Wood SD; Kelly TM; Salloum IM
Addict Behav; 2011 Aug; 36(8):843-8. PubMed ID: 21530092
[TBL] [Abstract][Full Text] [Related]
2. Double-blind placebo-controlled trial of fluoxetine in adolescents with comorbid major depression and an alcohol use disorder.
Cornelius JR; Bukstein OG; Wood DS; Kirisci L; Douaihy A; Clark DB
Addict Behav; 2009 Oct; 34(10):905-9. PubMed ID: 19321268
[TBL] [Abstract][Full Text] [Related]
3. Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults.
Cornelius JR; Bukstein OG; Douaihy AB; Clark DB; Chung TA; Daley DC; Wood DS; Brown SJ
Drug Alcohol Depend; 2010 Nov; 112(1-2):39-45. PubMed ID: 20576364
[TBL] [Abstract][Full Text] [Related]
4. LONGER-TERM EFFECTIVENESS OF CBT IN TREATMENT OF COMORBID AUD/MDD ADOLESCENTS.
Cornelius JR; Douaihy AB; Kirisci L; Daley DC
Int J Med Biol Front; 2013; 19(2):. PubMed ID: 25339844
[TBL] [Abstract][Full Text] [Related]
5. The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial.
Davey CG; Chanen AM; Hetrick SE; Cotton SM; Ratheesh A; Amminger GP; Koutsogiannis J; Phelan M; Mullen E; Harrison BJ; Rice S; Parker AG; Dean OM; Weller A; Kerr M; Quinn AL; Catania L; Kazantzis N; McGorry PD; Berk M
Lancet Psychiatry; 2019 Sep; 6(9):735-744. PubMed ID: 31371212
[TBL] [Abstract][Full Text] [Related]
6. TREATMENT TRIAL AND LONG-TERM FOLLOW-UP EVALUATION AMONG COMORBID YOUTH WITH MAJOR DEPRESSION AND A CANNABIS USE DISORDER.
Cornelius JR; Salloum IM; Ferrell R; Douaihy AB; Hayes J; Kirisci L; Horner M; Daley DC
Int J Med Biol Front; 2012; 18(6):399-411. PubMed ID: 25328373
[TBL] [Abstract][Full Text] [Related]
7. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
Goodyer IM; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
Health Technol Assess; 2008 May; 12(14):iii-iv, ix-60. PubMed ID: 18462573
[TBL] [Abstract][Full Text] [Related]
8. Onset of alcohol or substance use disorders following treatment for adolescent depression.
Curry J; Silva S; Rohde P; Ginsburg G; Kennard B; Kratochvil C; Simons A; Kirchner J; May D; Mayes T; Feeny N; Albano AM; Lavanier S; Reinecke M; Jacobs R; Becker-Weidman E; Weller E; Emslie G; Walkup J; Kastelic E; Burns B; Wells K; March J
J Consult Clin Psychol; 2012 Apr; 80(2):299-312. PubMed ID: 22250853
[TBL] [Abstract][Full Text] [Related]
9. Treatment of comorbid alcohol use disorders and depression with cognitive-behavioural therapy and motivational interviewing: a meta-analysis.
Riper H; Andersson G; Hunter SB; de Wit J; Berking M; Cuijpers P
Addiction; 2014 Mar; 109(3):394-406. PubMed ID: 24304463
[TBL] [Abstract][Full Text] [Related]
10. Symptom clusters in adolescent depression and differential response to treatment: a secondary analysis of the Treatment for Adolescents with Depression Study randomised trial.
Bondar J; Caye A; Chekroud AM; Kieling C
Lancet Psychiatry; 2020 Apr; 7(4):337-343. PubMed ID: 32199509
[TBL] [Abstract][Full Text] [Related]
11. Fluoxetine in depressed AUD adolescents: a 1-year follow-up evaluation.
Cornelius JR; Bukstein OG; Salloum IM; Kelly TM; Wood DS; Clark DB
J Child Adolesc Psychopharmacol; 2004; 14(1):33-8. PubMed ID: 15142389
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy, acceptability, and safety of medicinal, cognitive-behavioral therapy, and placebo treatments for acute major depressive disorder in children and adolescents: a multiple-treatments meta-analysis.
Ma D; Zhang Z; Zhang X; Li L
Curr Med Res Opin; 2014 Jun; 30(6):971-95. PubMed ID: 24188102
[TBL] [Abstract][Full Text] [Related]
13. Fluoxetine in adolescents with comorbid major depression and an alcohol use disorder: a 3-year follow-up study.
Cornelius JR; Clark DB; Bukstein OG; Kelly TM; Salloum IM; Wood DS
Addict Behav; 2005 May; 30(4):807-14. PubMed ID: 15833583
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic efficacy of fluoxetine, escitalopram, sertraline, paroxetine, and concomitant psychotherapy in major depressive disorder: outcome after long-term follow-up.
Peselow ED; Tobia G; Karamians R; Pizano D; IsHak WW
Psychiatry Res; 2015 Feb; 225(3):680-6. PubMed ID: 25496869
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders.
Riggs PD; Mikulich-Gilbertson SK; Davies RD; Lohman M; Klein C; Stover SK
Arch Pediatr Adolesc Med; 2007 Nov; 161(11):1026-34. PubMed ID: 17984403
[TBL] [Abstract][Full Text] [Related]
16. Prevention of Recurrence After Recovery From a Major Depressive Episode With Antidepressant Medication Alone or in Combination With Cognitive Behavioral Therapy: Phase 2 of a 2-Phase Randomized Clinical Trial.
DeRubeis RJ; Zajecka J; Shelton RC; Amsterdam JD; Fawcett J; Xu C; Young PR; Gallop R; Hollon SD
JAMA Psychiatry; 2020 Mar; 77(3):237-245. PubMed ID: 31799993
[TBL] [Abstract][Full Text] [Related]
17. Do comorbid social and other anxiety disorders predict outcomes during and after cognitive therapy for depression?
Vittengl JR; Clark LA; Smits JAJ; Thase ME; Jarrett RB
J Affect Disord; 2019 Jan; 242():150-158. PubMed ID: 30176494
[TBL] [Abstract][Full Text] [Related]
18. Continued Effectiveness of Relapse Prevention Cognitive-Behavioral Therapy Following Fluoxetine Treatment in Youth With Major Depressive Disorder.
Emslie GJ; Kennard BD; Mayes TL; Nakonezny PA; Moore J; Jones JM; Foxwell AA; King J
J Am Acad Child Adolesc Psychiatry; 2015 Dec; 54(12):991-8. PubMed ID: 26598474
[TBL] [Abstract][Full Text] [Related]
19. Mirtazapine in comorbid major depression and an alcohol use disorder: A double-blind placebo-controlled pilot trial.
Cornelius JR; Chung T; Douaihy AB; Kirisci L; Glance J; Kmiec J; FitzGerald D; Wesesky MA; Salloum I
Psychiatry Res; 2016 Aug; 242():326-330. PubMed ID: 27327217
[TBL] [Abstract][Full Text] [Related]
20. Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS).
Kennard B; Silva S; Vitiello B; Curry J; Kratochvil C; Simons A; Hughes J; Feeny N; Weller E; Sweeney M; Reinecke M; Pathak S; Ginsburg G; Emslie G; March J;
J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1404-11. PubMed ID: 17135985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
